Mounjaro 7.5 MG/0.5 ML pen 0.5ML
Ended Awarded
- Contract number
- SPE2DB25FWWV9
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $39,740
Award facts
- Contract value 100% obligated
- $39,739.70 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp for the supply of Mounjaro 7.5 mg/0.5 mL pen injections, with a contract ceiling value of $39,739.70. The award, issued on September 18, 2025, with an ultimate completion date of September 19, 2025, utilizes firm fixed-price pricing under a non-competitive, non-set-aside delivery order. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform this delivery from its corporate office location. This contract represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026.
Mounjaro is a prescription diabetes medication used for glycemic control in patients with type 2 diabetes. This delivery order exemplifies AmerisourceBergen's role as a critical pharmaceutical distributor within the federal medical supply chain, supporting military healthcare systems and other government health programs. The contract aligns with the DLA's medical supply procurement operations and reflects the company's established capability to deliver specialized pharmaceutical products competitively to federal customers. As a major pharmaceutical distributor with extensive experience fulfilling federal medical procurement requirements, AmerisourceBergen continues to support the Defense Health Agency and other military healthcare constituencies through its comprehensive pharmaceutical supply agreements.
Quick answers
Who was awarded contract SPE2DB25FWWV9?
SPE2DB25FWWV9 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 18, 2025.
How much is contract SPE2DB25FWWV9 worth?
The government has obligated $39,740 on SPE2DB25FWWV9.
Is contract SPE2DB25FWWV9 an order under another contract?
Yes. SPE2DB25FWWV9 is a delivery order under SPE2DB24D2018, an indefinite delivery contract.
Was contract SPE2DB25FWWV9 competed?
The extent of competition for SPE2DB25FWWV9 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award